Equities.com Interview with Rashid Ahmed CEO
Cambridge’s 2015 Vancouver Resource Investment Conference in a Nutshell
By Gaalen Engen, Stockhouse.com The 2015 Vancouver Resource Investment Conference, hosted by Cambridge House International, is a regional event that attracts junior from a variety of resource sectors to network, promote and exchange experience in an exciting environment rife with investors, analysts and media.In past years, this event has been the premier meeting ground for the […]
BioMark CBC Radio Interview
BioMark’s CEO Rashid Ahmed was interviewed by Rick Cluff from CBC Radio’s The Early Edition. The full interview is available online at the CBC Radio One [1:20:00] http://www.cbc.ca/earlyedition/pastepisodes/
BioMark Receives US Trading Symbol BMKDF from FINRA and Commences Trading in the USA
Press Release – BioMark Receives US Trading Symbol BMKDF (PDF) ———————————————
BioMark To Be On CBC Early Edition
Press Release – BIOMARK TO BE ON CBC EARLY EDITION (PDF) ———————————————
Global News: Richmond Company Develops Urine Cancer Test
Mon, Jan 5: A BC company is in the final stages of testing a simple new way of detecting cancer. Elaine Yong reports. Your browser does not support frames. Click here to view the frameless video.. Source: Global News http://globalnews.ca/video/1756747/richmond-company-develops-urine-cancer-test
Biomark Announces A Partial Closing Private Placement
Press Release-BIOMARK ANNOUNCES A PARTIAL CLOSING PRIVATE PLACEMENT-January 2, 2015 (PDF) ———————————————
BioMark Diagnostics at the equities.com Small-Cap Stars Conference at the NASDAQ MarketSite
We appreciate the opportunity speaking with BioMark Diagnostics at the equities.com Small-Cap Stars Conference at the NASDAQ MarketSite and to learn more about BioMark Diagnostics. Here is the link to your video interview: http://www.equities.com/media-gallery/384-brian-gusko-dir-of-corp-relations-for-biomark-diagnostics-bux?category_id=74
Biomark Diagnostics Develops Cancer Diagnostics Kit
Published by Canadian Investor on December 9, 2014 A newly listed company, Biomark Diagnostics, is making headlines with their cancer diagnostic technology, which is currently in Phase 3 clinical trials. The technology will enable patients to receive a non-invasive test for the diagnosis of many cancers. The Company’s patents and technology calls for the […]
BioMark Receives Health Canada Protocol Approval
Press Release – BioMark Receives Health Canada Protocol Approval (PDF) ———————————————